HIV Diagnostics Market Size & Forecast Report,
2012 - 2022
HIV Diagnostics Market is anticipated to reach USD 4.48 billion by 2022. The human immunodeficiency
virus (HIV) leads to Acquired Immuno Deficiency Syndrome (AIDS). HIV attacks the immune system;
thereby making one vulnerable to hoards of diseases. The factors that propel the growth of the HIV
Diagnostics industry include growing number of blood transfusions and blood donations, prevalence of
HIV/AIDS worldwide, assistance offered by point-of-care instruments & kits, and growing consciousness
about HIV/AIDS and rising administration initiatives.
On the other hand, there are factors that may hamper the growth of the market including absence of
acceptable testing labs, and restrictions of laboratory-based testing. HIV Diagnostics Market is
anticipated to grow at a significant CAGR of 9.5% in the upcoming period as the scope, product types, and
its applications are increasing across the globe.
Request a Free Sample Copy @ https://www.millioninsights.com/industry-reports/hiv-diagnostics-
HIV Diagnostics industry may be explored by Product type, end user, test type, and geography. The
market may be explored by product type as Instruments, Software and Services, Consumables, Kits,
Assay, and Reagents, and the other Consumables. The “Consumables” segment led the market in 2016
and is anticipated to maintain its dominance by 2025 due to rising occurrence of HIV/AIDS, and growing
enterprises from governments to fight HIV/AIDS.
The HIV Diagnostics Market could be explored based on end users as Hospitals, Diagnostics Laboratories,
Home care settings, Blood banks, and Others (Gene bank, cell bank, pharma companies, and
Biotechnology). The “Diagnostic Laboratories” segment led the market in 2016 and is anticipated to
maintain its dominance by 2022 owing to technological developments of diagnostics laboratories, and
high investment, and increasing consciousness of HIV/AIDS.
“HIV Diagnostics Market i